Can secondary syphilis initially present with a rash on the feet, and how sensitive are blood antibody tests (non‑treponemal and treponemal serology) at that stage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Secondary Syphilis Rash Can Absolutely Present on the Feet First

Yes, the rash of secondary syphilis classically involves the palms and soles (including feet), and blood antibody tests are highly accurate at this stage, with sensitivity of 97-100% for both nontreponemal (RPR/VDRL) and treponemal tests. 1, 2

Clinical Presentation on the Feet

The maculopapular rash of secondary syphilis characteristically affects the palms of the hands and soles of the feet bilaterally 2. This is actually one of the classic diagnostic features that should immediately raise suspicion for secondary syphilis. The rash can present as:

  • Painless macular or maculopapular lesions
  • Bilateral distribution on palms and soles
  • May be accompanied by diffuse body rash, fever, and lymphadenopathy 2, 3

Common pitfall: While the palms-and-soles distribution is classic, secondary syphilis can mimic many other dermatological conditions, so maintaining a high index of suspicion is critical 4.

Blood Test Accuracy at Secondary Stage

Nontreponemal Tests (RPR/VDRL)

At the secondary syphilis stage, nontreponemal tests are essentially perfect for diagnosis:

  • Sensitivity: 97-100% 1
  • The VDRL showed 100% sensitivity across high-quality studies
  • RPR showed 97.2-100% sensitivity 1

This is dramatically better than in primary syphilis (where sensitivity is only 62-78%) 1.

Treponemal Tests

Treponemal tests are equally excellent at this stage:

  • ELISA: 100% sensitivity for secondary syphilis 5
  • FTA-ABS: 96.3-98.7% sensitivity 5, 6
  • The Determine rapid test showed 100% sensitivity specifically for secondary syphilis 6

Diagnostic Algorithm

When you suspect secondary syphilis based on palms/soles rash:

  1. Order both nontreponemal (RPR or VDRL) AND treponemal tests - both are needed to distinguish active from past treated infection 7

  2. Expect positive results - at the secondary stage, false negatives are extremely rare (only 0-3% chance) 1, 5

  3. If initial screening is negative but clinical suspicion remains high, repeat testing in 1-2 weeks, though this is rarely necessary in true secondary syphilis

  4. Obtain quantitative titers on the nontreponemal test for treatment monitoring 3

Key Clinical Points

  • The secondary stage is when serologic testing is most reliable - you're in the optimal window for diagnosis 1
  • Both traditional and reverse algorithms (starting with treponemal vs. nontreponemal first) perform equally well at this stage 5
  • HIV co-infection does not significantly reduce test sensitivity at the secondary stage 6
  • Higher RPR titers (≥1:8) correlate with even better test performance 6

Bottom line: If you see a bilateral palms-and-soles rash, order syphilis serology immediately with high confidence that positive results will confirm your clinical diagnosis, as test sensitivity approaches 100% at this stage 1, 5.

References

Research

Secondary Syphilis.

Clinical practice and cases in emergency medicine, 2020

Research

Diagnosis and management of syphilis.

American family physician, 2003

Research

A complex presentation of complicated secondary syphilis with ulcerated lesion progression.

Nigerian medical journal : journal of the Nigeria Medical Association, 2025

Research

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.